药物与皮肤:皮肤药物不良反应简明综述
本文综述了皮肤药物不良反应(CADR)的定义、流行病学、临床类型、致病药物、发病机制及分类方法。CADR可影响高达10%的住院患者,在多重用药患者中发生率为1-3%,其中2-6.7%可能发展为危及生命的状况。识别特定CADR依赖于详细的临床检查、皮损形态描述及实验室和/或皮肤活检支持。
要点
- CADR可影响高达10%的住院患者,多重用药患者发生率为1-3%。
- 2-6.7%的CADR可能发展为危及生命的状况。
- 抗生素、非甾体抗炎药和抗癫痫药是最常涉及的药物。
核心结论
- CADR涵盖皮肤、黏膜和附件的临床表现,可由药物或其代谢物诱导。
- 大多数CADR轻微或自限,但2-6.7%可能发展为危及生命的状况。
- 识别特定CADR依赖于详细临床检查、皮损形态描述及实验室和/或皮肤活检支持。
研究设计与样本
- 本文为简明综述,总结CADR的临床类型、致病药物、发病机制及分类方法。
主要发现
- CADR可影响高达10%的住院患者,在多重用药患者中发生率为1-3%。
- 2-6.7%的CADR可能发展为危及生命的状况。
- 目前报道的皮肤药物反应模式有29-35种。
- 最常见的报告类型为斑丘疹、荨麻疹/血管性水肿、固定性药疹和多形性红斑。
- 较少见但更严重的类型包括红皮病、伴嗜酸性粒细胞增多和系统症状的药物反应以及Stevens-Johnson综合征/中毒性表皮坏死松解症谱系。
关键数值与推荐
- CADR可按以下方式分类:A型(增强型)或B型(奇异型);速发型或迟发型;免疫介导或非免疫介导;非严重或危及生命;按表型包括发疹性、荨麻疹性、脓疱性和大疱性形态。
临床怎么用
- 临床识别CADR应进行详细临床检查,正确描述皮损形态,并辅以实验室和/或皮肤活检。
局限性
- 部分CADR的发病机制仍未知。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Drug-induced skin disease or cutaneous adverse drug reactions (CADRs) are terms that encompass the clinical manifestations of the skin, mucosae and adnexa induced by a drug or its metabolites. The skin is the organ most frequently affected by drug reactions, which may affect up to 10% of hospitalized patients and occur in 1-3% of multimedicated patients. Most CADRs are mild or self-resolving conditions; however, 2-6.7% of could develop into potentially life-threatening conditions. CADRs represent a heterogeneous field and can be diagnostically challenging as they may potentially mimic any dermatosis. Currently, there are between 29-35 different cutaneous drug-reaction patterns reported ranging from mild dermatitis to an extensively burnt patient. The most frequently reported are maculopapular rash, urticaria/angioedema, fixed drug eruption and erythema multiforme. Less common but more severe patterns include erythroderma, drug reaction with eosinophilia and systemic symptoms, and Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum. Almost any drug can induce a CADR, but antibiotics, nonsteroidal anti-inflammatory drugs and antiepileptics are the most frequently involved. Different mechanisms are involved in the pathogenesis of CADRs, although in some cases, these remain still unknown. CADRs could be classified in different ways: (i) type A (augmented) or type B (bizarre); (ii) immediate or delayed; (iii) immune-mediated or nonimmune-mediated; (iv) nonsevere or life-threatening; and (v) by their phenotype, including exanthematous, urticarial, pustular and blistering morphology. Recognizing a specific CADR will mostly depend on the ability of the physician to perform a detailed clinical examination, the proper description of the morphology of the skin lesions and supporting laboratory and/or skin biopsy findings.
引用
- Del Pozzo-Magaña BR, Liy-Wong C. Drugs and the skin: A concise review of cutaneous adverse drug reactions. Br J Clin Pharmacol. 2022. PMID: 35974692. doi:10.1111/bcp.15490
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。